Results
102
Companys with strong funding and high growth potential
102 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
BOVN.F | SEK 4.70 | 0% | n/a | SEK 2.7b | SEK 12.58 | PS9.2x | E62.0% | n/a | Pharmaceuticals & Biotech | ||
0RV2 | SEK 157.90 | -3.4% | -42.1% | SEK 13.9b | SEK 292.09 | PS46.4x | E98.4% | 0% | Pharmaceuticals & Biotech | ||
IMGN | US$31.23 | 6.6% | 617.9% | US$8.4b | US$28.95 | PS29.1x | E45.8% | n/a | Pharmaceuticals & Biotech | ||
SGEN | US$228.74 | 4.5% | 76.5% | US$43.2b | US$228.91 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech | ||
0A8R | US$228.95 | 4.6% | 81.1% | US$43.2b | US$229.12 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech | ||
ARGX | €547.28 | 5.3% | 15.8% | €29.4b | €567.97 | PS19.6x | E58.5% | n/a | Pharmaceuticals & Biotech | ||
IVVD | US$0.90 | -8.2% | -45.4% | US$107.5m | US$8.65 | PS47.5x | E70.4% | n/a | Pharmaceuticals & Biotech | ||
0A8K | US$31.24 | 6.4% | 658.3% | US$8.4b | US$29.16 | PS29.1x | E45.9% | n/a | Pharmaceuticals & Biotech | ||
ARDX | US$6.85 | 15.5% | 71.7% | US$1.6b | US$11.28 | PS7.7x | E66.4% | n/a | Pharmaceuticals & Biotech | ||
BIOABS | SEK 158.45 | -8.9% | -43.4% | SEK 13.9b | SEK 293.10 | PS46.4x | E98.4% | 0% | Pharmaceuticals & Biotech | ||
ARGN.F | €525.60 | 0% | 16.0% | €29.4b | €545.19 | PS19.6x | E58.4% | n/a | Pharmaceuticals & Biotech | ||
BRCT.F | SEK 15.56 | -7.9% | -39.4% | SEK 13.9b | SEK 28.52 | PS46.8x | E98.4% | 0% | Pharmaceuticals & Biotech | ||
AKES.F | HK$8.89 | 17.1% | n/a | HK$59.4b | HK$8.53 | PS28.6x | E54.5% | n/a | Pharmaceuticals & Biotech | ||
ARGXB | €491.35 | 2.0% | 5.6% | €29.4b | €509.93 | PS19.6x | E58.5% | n/a | Pharmaceuticals & Biotech | ||
0QW0 | €487.45 | -0.03% | 7.0% | €29.4b | €505.62 | PS19.6x | E58.4% | n/a | Pharmaceuticals & Biotech | ||
BPMC | US$90.00 | -0.3% | 85.5% | US$5.9b | US$127.35 | PS15.7x | E67.4% | n/a | Pharmaceuticals & Biotech | ||
0HOJ | US$89.14 | 0.006% | 80.4% | US$5.7b | US$126.13 | PS15.7x | E67.4% | n/a | Pharmaceuticals & Biotech | ||
ISEE | US$39.95 | 0.9% | 236.3% | US$5.5b | US$40.00 | PB11.6x | E59.0% | n/a | Pharmaceuticals & Biotech | ||
ALDX | US$5.29 | -6.4% | -9.6% | US$320.3m | US$10.00 | PB3.2x | E62.3% | n/a | Pharmaceuticals & Biotech | ||
ENSC | US$0.23 | -23.7% | -81.9% | US$2.6m | US$8.60 | PS1.7x | E99.1% | n/a | Pharmaceuticals & Biotech | ||
IVBI.Y | HK$22.00 | 0% | n/a | HK$76.8b | HK$27.44 | PS9.3x | E59.4% | n/a | Pharmaceuticals & Biotech | ||
MDGL | US$209.33 | -6.2% | 48.7% | US$4.6b | US$360.57 | PS310.5x | E68.1% | n/a | Pharmaceuticals & Biotech | ||
SWTX | US$32.22 | 0.2% | 33.3% | US$2.4b | US$68.13 | PS27.8x | E75.6% | n/a | Pharmaceuticals & Biotech | ||
MGTX | US$4.15 | 3.0% | -9.0% | US$322.8m | US$20.60 | PS39.5x | E7.8% | n/a | Pharmaceuticals & Biotech |